Indian Hospital Chain To Enter Drug-Making Business By Buying Firm
This article was originally published in PharmAsia News
India's largest hospital chain plans to get into the pharmaceutical business through an acquisition and into clinical trials in collaboration with foreign companies. Apollo Hospitals sees an opportunity to get into the drugs end of the health care at a time of depressed prices brought on by a bad global economy. Apollo, through a wholly owned subsidiary, already is close to signing joint ventures with two U.S. companies for Phase I and II trials of cancer and heart drugs. The Apollo group also conducts Phase III trials for several companies. (Click here for more
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.